A Multicentre, Prospective, Open-label, Single-arm Clinical Study of the Safety and Feasibility of Using Navigational Bronchoscopy to Perform Interstitial Photodynamic Therapy Using Photofrin® as Treatment in Subjects With Unresectable Stage IA Peripheral Non-small Cell Lung Cancer (NSCLC)
This research study is being conducted to assess the safety and feasibility of using a new
developed bronchoscopic technology called electronavigational bronchoscopy to treat subjects
with peripheral stage T1A non-small cell lung cancer (NSCLC), who are inoperable or refused
surgery, and are not candidates or refused radiation therapy. It will involve 10 sites in
USA and Canada. Participation will last 6 months.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society